Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group
about
Debate: transfusing to normal haemoglobin levels will not improve outcomeAnemia and blood transfusions in critically ill patientsCost-effectiveness of testing for human immunodeficiency virus and hepatitis C virus among blood transfusion recipients.Transfusion transmitted infection. Did authors systematically underestimate risks of transfusion?Management of occult hepatitis B virus infection: an update for the clinician.The risks associated with blood and blood product transfusion.Recombinant erythropoietin in clinical practice.Occult hepatitis B virus infection: implications in transfusion.Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.Pre-operative predeposit autologous donation in children presenting for elective surgery: a review.PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.Occult hepatitis B: clinical viewpoint and management.Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.European guideline for the management of hepatitis B and C virus infections.Adult T-cell leukemia/lymphoma (ATLL): report of two fully documented Hellenic patients.Bayesian evaluation of the human immunodeficiency virus antibody screening strategy of duplicate enzyme-linked immunosorbent assay in Xuzhou Blood Center, China.Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions.Cerebral and peripheral near-infrared spectroscopy: an alternative transfusion trigger?Identifying patients for blood conservation strategies.Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.Efficacy and Safety of Artiss Fibrin Tissue Sealant Use in Rhytidectomy: A Review of 120 Cases.Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) surveyAn estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy
P2860
Q24795926-3B439EBA-7D7D-4AAF-B363-93B0E0BFFECFQ26822895-75D89256-5F5F-476A-A9E4-87347006190CQ31132856-0C909BEB-66D2-456C-8D5E-A68B37D169BCQ33801988-A64A3EFA-20D5-4157-8E5A-F2F1EFD48D6AQ34757408-205B7B97-AA96-4F7D-8B46-3016FD931902Q34883232-D176FE66-3E32-4979-99B8-9A96476871E2Q35190989-3DBFA44A-D6EA-49D4-A5E5-0D6E0B6A4D7DQ35691937-9554B72B-D9BE-47FB-8F27-6DB278F29A2CQ35824825-A504E02B-5826-4525-B8DF-C986ED86E93DQ36790014-FB51E5D9-4A6F-4299-AAA3-F2F8F93FF652Q40606238-1FEE04BD-4B98-4517-BBF0-01EE871BFFD6Q43223881-B2BBAFE3-123C-4565-A1B3-5A99F40BC8C4Q44017424-06CFCC8F-5ABD-4ECD-AD50-69DC9838D939Q44118049-A2A67789-2D4F-4B9D-94D7-CDA869FC6C8FQ44908708-F82E5F05-40BF-4B72-B83E-3F0AD8B7C0CBQ45372714-169B6F80-03ED-4D62-A67D-7F2F017A58CEQ45423755-4E46E59F-E3B0-4D5F-91DF-81053C19F533Q45723531-4C65190C-3F93-4093-BB58-633808E195A0Q48474543-411D7AD9-AA0D-4DF3-A78C-0A6651B0AC81Q49059607-CC405325-E47B-4DC5-9F2B-67A9C9BC8783Q52030298-3788468C-5F1B-4C3B-A684-203627B0541BQ53103267-FB1DC416-3C25-43E9-BCC4-665CBB6FB593Q58776091-082CF5EF-F17C-4412-84F2-749DCFD59763Q58803030-71371180-CD69-4336-9677-0AD00615F91B
P2860
Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective investigation of t ...... nits of blood. TTI Study Group
@en
Prospective investigation of t ...... its of blood. TTI Study Group.
@nl
type
label
Prospective investigation of t ...... nits of blood. TTI Study Group
@en
Prospective investigation of t ...... its of blood. TTI Study Group.
@nl
prefLabel
Prospective investigation of t ...... nits of blood. TTI Study Group
@en
Prospective investigation of t ...... its of blood. TTI Study Group.
@nl
P2093
P2860
P356
P1433
P1476
Prospective investigation of t ...... nits of blood. TTI Study Group
@en
P2093
J A Barbara
M Contreras
P2860
P304
P356
10.1136/BMJ.320.7232.403
P407
P577
2000-02-01T00:00:00Z